Skip to main content

Table 2 Antibiotic, Bronchodilator and Steroid use Prior to and Following CEM Introduction

From: Effect of point of care information on inpatient management of bronchiolitis

  Pre-CEM 2000 – 2001 n = 142 Post-CEM 2001 – 2002 n = 174 Difference (95% CI) p-value
Antibiotic Prescription Patterns for Bronchiolitis Patients
Antibiotics, n (%) 49 (34.5) 38 (21.8) 12.7 (2.7, 22.5) 0.020
# antibiotics received:     
   0, n (%) 93 (65.5) 136 (78.2)   
   1, n (%) 28 (19.7) 22 (12.6)   
   2, n (%) 16 (11.3) 12 (6.9)   
   3, n (%) 4 (2.8) 3 (1.7)   
   4, n (%) 1 (0.7) 1 (0.6)   
Median (range) 0 (0, 4) 0 (0, 4) 0 (0,0) 0.019
Bronchodilator Prescription Patterns for Bronchiolitis Patients
Bronchodilators, n(%) 134 (94.4) 163 (93.7) 0.7 (-5.1, 6.1) 0.873
Salbutamol received, n (%) 102 (71.8) 77 (44.3) 27.6 (16.9, 37.4) <0.001
Epinephrine received, n (%) 72 (50.7) 120 (69.0) -18.3 (-28.6, -7.4) 0.005
Number of different bronchodilators received     
   0 received, n (%) 8 (5.6) 11 (6.3)   
   1 received, n (%) 57 (40.1) 64 (36.8)   
   2 received, n (%) 37 (26,1) 37 (21.3)   
   3 received, n (%) 18 (12.7) 34 (19.5)   
   ≥ 4 received, n (%) 22 (15.5) 28 (16.1)   
Median (range) 2 (0, 8) 2 (0, 9) 0 (0, 0) 0.637
Steroid Prescription Patterns for Bronchiolitis Patients
Inhaled Steroids     
   0, n (%) 132 (93.0) 167 (96.0)   
   1, n (%) 10 (7.0) 6 (3.4)   
   2, n (%) 0 (0.0) 1 (0.6)   
   Median (range) 0 (0, 1) 0 (0, 2) 0 (0, 0) 0.510
Systemic Steroids     
   0, n (%) 129 (90.8) 157 (90.2)   
   1, n (%) 13 (9.2) 17 (9.8)   
   Median (range) 0 (0, 1) 0 (0,1) 0 (0, 0) 0.629
Total Inhaled and Systemic steroids     
   0, n (%) 122 (85.9) 152 (87.4)   
   1, n (%) 17 (12.0) 19 (10.9)   
   2, n (%) 3 (2.1) 3 (1.7)   
   Median (range) 0 (0, 2) 0 (0,2) 0 (0, 0) 0.983